scholarly journals Influence of breast density on patient's compliance during ultrasound examination: Conventional handheld breast ultrasound compared to automated breast ultrasound

2020 ◽  
Vol 0 (0) ◽  
pp. 0
Author(s):  
SaraDe Giorgis ◽  
Nicole Brunetti ◽  
Jeries Zawaideh ◽  
Federica Rossi ◽  
Massimo Calabrese ◽  
...  
2013 ◽  
Vol 35 (4) ◽  
pp. 333-343 ◽  
Author(s):  
Woo Kyung Moon ◽  
Chung-Ming Lo ◽  
Jung Min Chang ◽  
Min Sun Bae ◽  
Won Hwa Kim ◽  
...  

Author(s):  
Yasser I. Abd Elkhalek ◽  
Ahmed M. Bassiouny ◽  
Rasha Wessam Abdel Rahman Abdel Hamid

Abstract Background Mammography is the most accepted, accurate, and effective modality in screening of breast cancer, yet its sensitivity is affected by the density of the breast tissue. Alternative methods for screening are the sonography and MRI but both had their limitations. A new option named ABUS (automated breast ultrasound system) is now proposed to overcome the breast US limitation as it is time-consuming and operator-dependent and to overcome the costly time-consuming MRI. The objectives of the study are to evaluate the accuracy of ABUS in the detection of different breast lesions as a substitution for mammography. This prospective study included 25 women outreached for digital mammography or handheld ultrasound examination at the period between January 2017 and February 2018. Women have no specific age group. Results Significant improvement in the detection of breast lesions by ABUS use with mammogram especially in dense breasts (ACR class C and D) Conclusion ABUS is a promising competitor to mammogram in screening of breast lesions


Choonpa Igaku ◽  
2020 ◽  
Author(s):  
Ayami SHIMIZU ◽  
Yuko HASHIMOTO ◽  
Tsuyoshi TABATA ◽  
Kazuhiro SHIMIZU ◽  
Nobuo TAKADA

Author(s):  
Iris Allajbeu ◽  
Sarah E Hickman ◽  
Nicholas Payne ◽  
Penelope Moyle ◽  
Kathryn Taylor ◽  
...  

Abstract Purpose of Review Automated breast ultrasound (ABUS) is a three-dimensional imaging technique, used as a supplemental screening tool in women with dense breasts. This review considers the technical aspects, pitfalls, and the use of ABUS in screening and clinical practice, together with new developments and future perspectives. Recent Findings ABUS has been approved in the USA and Europe as a screening tool for asymptomatic women with dense breasts in addition to mammography. Supplemental US screening has high sensitivity for cancer detection, especially early-stage invasive cancers, and reduces the frequency of interval cancers. ABUS has similar diagnostic performance to handheld ultrasound (HHUS) and is designed to overcome the drawbacks of operator dependence and poor reproducibility. Concerns with ABUS, like HHUS, include relatively high recall rates and lengthy reading time when compared to mammography. ABUS is a new technique with unique features; therefore, adequate training is required to improve detection and reduce false positives. Computer-aided detection may reduce reading times and improve cancer detection. Other potential applications of ABUS include local staging, treatment response evaluation, breast density assessment, and integration of radiomics. Summary ABUS provides an efficient, reproducible, and comprehensive supplemental imaging technique in breast screening. Developments with computer-aided detection may improve the sensitivity and specificity as well as radiologist confidence and reduce reading times, making this modality acceptable in large volume screening centers.


2016 ◽  
Vol 58 (5) ◽  
pp. 515-520 ◽  
Author(s):  
Roxanna Hellgren ◽  
Paul Dickman ◽  
Karin Leifland ◽  
Ariel Saracco ◽  
Per Hall ◽  
...  

Background Automated breast volume scanner (ABVS) is an ultrasound (US) device with a wide scanner that sweeps over a large area of the breast and the acquired transverse images are sent to a workstation for reconstruction and review. Whether ABVS is as reliable as handheld US is, however, still not established. Purpose To compare the sensitivity and specificity of ABVS to handheld breast US for detection of breast cancer, in the situation of recall after mammography screening. Material and Methods A total of 113 women, five with bilateral suspicious findings, undergoing handheld breast US due to a suspicious mammographic finding in screening, underwent additional ABVS. The methods were assessed for each breast and each detected lesion separately and classified into two categories: breasts with mammographic suspicion of malignancy and breasts with a negative mammogram. Results Twenty-six cancers were found in 25 women. In the category of breasts with a suspicious mammographic finding (n = 118), the sensitivity of both handheld US and ABVS was 88% (22/25). The specificity of handheld US was 93.5% (87/93) and ABVS was 89.2% (83/93). In the category of breasts with a negative mammography (n = 103), the sensitivity of handheld US and ABVS was 100% (1/1). The specificity of handheld US was 100% (102/102) and ABVS was 94.1% (96/102). Conclusion ABVS can potentially replace handheld US in the investigation of women recalled from mammography screening due to a suspicious finding. Due to the small size of our study population, further investigation with larger study populations is necessary before the implementation of such practice.


2019 ◽  
Vol 21 (2) ◽  
pp. 200
Author(s):  
Anca Ileana Ciurea ◽  
Ioana Boca ◽  
Liliana Rogojan ◽  
Larisa Dorina Ciule ◽  
Cristiana Augusta Ciortea

Metastases to the skeletal muscle from breast cancer represent an unusual and rare condition. We present the case of a 27-year-old female with left breast cancer (IDC NST G3) who underwent neoadjuvant chemotherapy followed by conservativesurgery (sectorectomy and lymphadenectomy) and radiation therapy. Two months after the end of radiotherapy she presented with a 2 mm skin lesion and she was referred for a screening ultrasound. The screening automated breast ultrasound (ABUS) revealed local recurrence and pectoralis metastases, lesions evaluated also by magnetic resonance imaging. The diagnosis was confirmed by the ultrasound-guided biopsy.


2021 ◽  
Author(s):  
Benedikt Schaefgen ◽  
Marija Juskic ◽  
Madeleine Hertel ◽  
Richard G Barr ◽  
Marcus Radicke ◽  
...  

Abstract Purpose: The FUSION-X-US-II prototype was developed to combine 3D-automated breast ultrasound (ABUS) and digital breast tomosynthesis in a single device without decompressing the breast. We evaluated the technical function, feasibility of the examination workflow, image quality, breast tissue coverage and patient comfort of the ABUS device of the new prototype. Methods: In this prospective feasibility study, the FUSION-X-US-II prototype was used to perform ABUS in 30 healthy volunteers without history of breast cancer. The ABUS images of the prototype were interpreted by a physician with specialization in breast diagnostics. Any detected lesions were measured and classified using BI-RADS® scores. Image quality was rated subjectively by the physician and coverage of the breast was measured. Patient comfort was evaluated by a questionnaire after the examination. Results: 106 scans were performed (61 x CC, 23 x ML, 22 x MLO) in 60 breasts. Image acquisition and processing by the prototype was fast and accurate. Breast coverage by ABUS was approximately 90.8%. 16 breast lesions (all benign, classified as BIRADS® 2) were identified. The examination was tolerated by all patients. Conclusion: The FUSION-X-US-II prototype allows a rapid ABUS scan with mostly high patient comfort. Technical developments resulted in an improvement of quality and coverage compared to previous prototype versions. The results are encouraging for a test of the prototype in a clinical setting in combination with tomosynthesis.


Sign in / Sign up

Export Citation Format

Share Document